BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 10566726)

  • 21. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic diagnosis of refractory ulcerative colitis.
    Hirata I; Murano M
    Inflammopharmacology; 2007 Feb; 15(1):22-5. PubMed ID: 17323191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time.
    Kleer CG; Appelman HD
    Am J Surg Pathol; 1998 Aug; 22(8):983-9. PubMed ID: 9706978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    Colorectal Dis; 2006 Sep; 8(7):551-6. PubMed ID: 16919105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.
    D'Haens G; Geboes K; Peeters M; Baert F; Ectors N; Rutgeerts P
    Am J Gastroenterol; 1997 Aug; 92(8):1275-9. PubMed ID: 9260788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
    Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
    Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis.
    Almer S; Kald B; Franzén L; Ström M; Tagesson C
    Eur J Surg; 1996 May; 162(5):391-6. PubMed ID: 8781921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitis patients?
    Kato J; Kuriyama M; Hiraoka S; Yamamoto K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):683-7. PubMed ID: 21054518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
    Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
    Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of sigmoidoscopy and rectal biopsy in diagnosis and management of inflammatory bowel disease: personal experience.
    Fochios SE; Korelitz BI
    Am J Gastroenterol; 1988 Feb; 83(2):114-9. PubMed ID: 3341332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
    Hafer A; Krämer S; Duncker S; Krüger M; Manns MP; Bischoff SC
    BMC Gastroenterol; 2007 Sep; 7():36. PubMed ID: 17784949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic biopsy features and diagnostic challenges of adult Crohn's disease at initial presentation.
    Kumarasinghe MP; Quek TP; Chau CY; Mustapha NR; Luman W; Ooi CJ
    Pathology; 2010 Feb; 42(2):131-7. PubMed ID: 20085514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease.
    Yantiss RK; Odze RD
    Am J Gastroenterol; 2007 Apr; 102(4):890-904. PubMed ID: 17324129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Xia Q
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic rectal sparing in children with untreated ulcerative colitis.
    Rajwal SR; Puntis JW; McClean P; Davison SM; Newell SJ; Sugarman I; Stringer MD
    J Pediatr Gastroenterol Nutr; 2004 Jan; 38(1):66-9. PubMed ID: 14676597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
    Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulcerative colitis with skip lesions at the mouth of the appendix: a clinical study.
    Okawa K; Aoki T; Sano K; Harihara S; Kitano A; Kuroki T
    Am J Gastroenterol; 1998 Dec; 93(12):2405-10. PubMed ID: 9860400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
    Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.